New scan spots tumors more clearly?
NCT ID NCT05556473
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early study tests a special PET/CT scan that uses a modified tryptophan molecule to make tumors light up more clearly than normal tissue. About 24 adults with brain, breast, neuroendocrine, or rectal cancers will get one scan to see if this method helps doctors tell tumors apart from healthy tissue. The goal is to improve future treatment planning, not to treat the cancer itself.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Karmanos Cancer Institute
RECRUITINGDetroit, Michigan, 48201, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Can a personalized exercise program boost recovery in cancer survivors?
- Smartwatch could spot nerve damage before it starts
- Digital nurse companion: could an app ease the burden of chronic illness?
- Could ionized gas help fight breast cancer after surgery?
- Radiation may let breast cancer patients keep their nipple